General Information of Drug Off-Target (DOT) (ID: OT59TQ6P)

DOT Name Small membrane A-kinase anchor protein (C2ORF88)
Synonyms Small membrane AKAP; smAKAP
Gene Name C2ORF88
Related Disease
Juvenile idiopathic arthritis ( )
UniProt ID
SMAKA_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
5HVZ
Pfam ID
PF15127
Sequence
MGCMKSKQTFPFPTIYEGEKQHESEEPFMPEERCLPRMASPVNVKEEVKEPPGTNTVILE
YAHRLSQDILCDALQQWACNNIKYHDIPYIESEGP
Function Binds to type I regulatory subunits of protein kinase A (PKA-RI) and may anchor/target them to the plasma membrane.
Tissue Specificity Expressed in heart (at protein level).

Molecular Interaction Atlas (MIA) of This DOT

1 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Juvenile idiopathic arthritis DISQZGBV Strong Biomarker [1]
------------------------------------------------------------------------------------
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
11 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the expression of Small membrane A-kinase anchor protein (C2ORF88). [2]
Ciclosporin DMAZJFX Approved Ciclosporin decreases the expression of Small membrane A-kinase anchor protein (C2ORF88). [3]
Tretinoin DM49DUI Approved Tretinoin decreases the expression of Small membrane A-kinase anchor protein (C2ORF88). [4]
Acetaminophen DMUIE76 Approved Acetaminophen decreases the expression of Small membrane A-kinase anchor protein (C2ORF88). [5]
Doxorubicin DMVP5YE Approved Doxorubicin decreases the expression of Small membrane A-kinase anchor protein (C2ORF88). [6]
Cupric Sulfate DMP0NFQ Approved Cupric Sulfate decreases the expression of Small membrane A-kinase anchor protein (C2ORF88). [7]
Cisplatin DMRHGI9 Approved Cisplatin increases the expression of Small membrane A-kinase anchor protein (C2ORF88). [8]
Urethane DM7NSI0 Phase 4 Urethane decreases the expression of Small membrane A-kinase anchor protein (C2ORF88). [10]
SNDX-275 DMH7W9X Phase 3 SNDX-275 increases the expression of Small membrane A-kinase anchor protein (C2ORF88). [2]
Bisphenol A DM2ZLD7 Investigative Bisphenol A increases the expression of Small membrane A-kinase anchor protein (C2ORF88). [12]
GALLICACID DM6Y3A0 Investigative GALLICACID increases the expression of Small membrane A-kinase anchor protein (C2ORF88). [13]
------------------------------------------------------------------------------------
⏷ Show the Full List of 11 Drug(s)
2 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Arsenic DMTL2Y1 Approved Arsenic affects the methylation of Small membrane A-kinase anchor protein (C2ORF88). [9]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene decreases the methylation of Small membrane A-kinase anchor protein (C2ORF88). [11]
------------------------------------------------------------------------------------

References

1 Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets.Arthritis Rheum. 2009 Jul;60(7):2113-23. doi: 10.1002/art.24534.
2 Definition of transcriptome-based indices for quantitative characterization of chemically disturbed stem cell development: introduction of the STOP-Toxukn and STOP-Toxukk tests. Arch Toxicol. 2017 Feb;91(2):839-864.
3 Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification. Toxicol Sci. 2010 May;115(1):66-79.
4 Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells. Cells. 2020 Nov 5;9(11):2423. doi: 10.3390/cells9112423.
5 Multiple microRNAs function as self-protective modules in acetaminophen-induced hepatotoxicity in humans. Arch Toxicol. 2018 Feb;92(2):845-858.
6 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
7 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
8 Activation of AIFM2 enhances apoptosis of human lung cancer cells undergoing toxicological stress. Toxicol Lett. 2016 Sep 6;258:227-236.
9 Prenatal arsenic exposure and the epigenome: identifying sites of 5-methylcytosine alterations that predict functional changes in gene expression in newborn cord blood and subsequent birth outcomes. Toxicol Sci. 2015 Jan;143(1):97-106. doi: 10.1093/toxsci/kfu210. Epub 2014 Oct 10.
10 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
11 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
12 Bisphenol A and bisphenol S induce distinct transcriptional profiles in differentiating human primary preadipocytes. PLoS One. 2016 Sep 29;11(9):e0163318.
13 Gene expression profile analysis of gallic acid-induced cell death process. Sci Rep. 2021 Aug 18;11(1):16743. doi: 10.1038/s41598-021-96174-1.